My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
September 2011
Patient Care and Science
CDC Makes New Recommendations for Influenza Immunization

The Centers for Disease Control and Prevention (CDC) in August released this year’s recommendations on influenza vaccination, including some changes affecting young children and people with egg allergies.

This year’s vaccine targets the same three strains as last year: A/California/7/2009 (H1N1)-like, A/Perth/16/2009 (H3N2)-like, and B/Brisbane/60/2008-like antigens. Even though the vaccine is unchanged, CDC advises annual vaccination because levels of protective antibodies can decrease, especially in the elderly and people with compromised immune systems.

Experts have known for some time that children aged 6 months through 8 years require two doses of influenza vaccine during their first season of vaccination. This year, however, because the vaccine strains are unchanged, children in this age group who received at least one dose of the 2010-2011 vaccine will require only one dose of the 2011-2112 vaccine. Children in this age group who did not receive at least one dose last year or whose immunization status is uncertain should receive two doses.

Also new this year is more in-depth advice concerning people with egg allergies. Several recent studies have documented safe receipt of trivalent inactivated vaccine (TIV) in people with egg allergy, particularly those with less severe reactions. CDC now advises that people who have had only hives after exposure to eggs should receive TIV from providers who are familiar with egg allergy and should be observed for at least 30 minutes after vaccination to monitor for possible reactions. People who have had more serious reactions to eggs (e.g., angioedema, respiratory distress, lightheadedness, recurrent vomiting, or those who required emergency medical care) should consult with an allergist before receiving the vaccine.

Last year was the first year that CDC recommended universal influenza immunization for everyone over 6 months of age. With vaccine manufactures projecting to have between 166 million and 173 million doses of vaccine on the U.S. market this season, CDC says the supply should be ample in September and October.

For the full recommendations, see:

Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011. MMWR. 2011 Aug. 18;60(early release):1-6
How useful is this article?

Next Article >

Post a comment

Your name:

Your comment:


Patient Care and Science
CDC Makes New Recommendations for Influenza Immunization
EIN Update: CBC Monitoring for ID-Related Diseases
Drug Approvals, Recalls, Adverse Events Update
Global ID
Armed with Research on Early HIV Treatment, HIVMA and Global Center Make Case for More Funding
Congressional Staff Tours U.S.-funded HIV and TB programs in Kenya with Global Center
Science Speaks Interviews Key PEPFAR Staff
Policy and Advocacy
Policy Conference Addresses Lack of New Antibiotics
FDA Rolls Out New Foodborne Illness Response Network
Input Due Oct. 26 on Changes to Rules Protecting Human Research Subjects
IDSA Urges Fix to Flawed Medicare Physician Payment Formula
Your Colleagues
IDSA Congratulates the 2011 Joint Research Award Winners
Congratulations to the 2011 Medical Scholars Program Recipients
In Memoriam: Richard B. Hornick, MD, FIDSA (1929-2011)
Members on the Move
Welcome, New Members!
Education & Resources
New Toolkit Aims to Increase Pneumococcal Immunization in Adults
HIVMA Minority Clinical Fellowship Program: December 9 Application Deadline
Top Stories
From the President: A Year in Review
IDSA, PIDS Release Guidelines for Treating CAP in Children
Quick Guide to the New IDSA Website
IDSA Journal Club
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'info@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.